AMA releases framework assigning liability when clinical AI harms patients

The American Medical Association released a framework on Oct. 29 for assigning liability when clinical AI harms patients, Becker's Hospital Review reported. Its organizing principle is simple to state: responsibility should align with each party's authority and ability to prevent or mitigate harm. The AMA Center for Digital Health and AI said existing liability frameworks were not built for technologies that physicians, developers and healthcare organizations each partly control.

That shared control is the practical problem for anyone running a health system or practice. A clinical AI tool may be built by a developer, configured and deployed by the organization, and acted on by a physician at the point of care. When something goes wrong, the question of who could have caught it, and who had the power to change it, is rarely written down anywhere. The AMA's framing turns that question into the center of the analysis. For a Chief AI Officer, it is a governance design prompt. For compliance and legal teams, it is a lens for reading contracts. For physicians, it speaks directly to how much of the risk sits with the clinician who accepts or overrides a recommendation.

The limits of the evidence matter here. This is a policy framework from a professional association. It is not law, regulation or case precedent, and the source does not indicate that any court or regulator has adopted it. What it offers is a widely recognized statement of how one of medicine's largest professional bodies thinks liability should be allocated. That can shape expectations in contract negotiations and internal policy even before it shapes any legal outcome.

The move is concrete. Inventory every clinical AI tool in production and, for each one, record who controls its configuration, who monitors its performance, and who can override or switch it off. Then compare that map with the vendor contracts. Where a vendor controls a function, such as model updates, the agreement should reflect that responsibility rather than leaving it with the organization or the clinician by default. Where the organization controls monitoring, it should have the staffing and process to actually do it.

The return is clarity for the people who use these tools every day. Physicians and nurses work with more confidence when they know where their accountability begins and ends, and patients benefit when every party with the ability to prevent harm is clearly expected to do so.

You are a clinical AI governance advisor to the Chief AI Officer and executive team of [your organization], a [type of health organization].

The American Medical Association released a framework on Oct. 29 that aligns liability for clinical AI harm with each party's authority and ability to prevent or mitigate it, as Becker's Hospital Review reported. The AMA Center for Digital Health and AI said existing liability frameworks were not built for tools that physicians, developers and organizations each partly control. This is a policy framework from a professional association. It is not law, regulation or case precedent, and the source does not indicate that any court or regulator has adopted it.

Your task: for each clinical AI tool we have in production, record who controls its configuration, who monitors its performance, and who can override or switch it off. The party may be the developer, our organization or the physician at the point of care. Then compare that map with each vendor contract. Identify where the agreement does not reflect the split, for example where the vendor controls model updates but the contract leaves that responsibility with us or the clinician by default. Also flag where we control monitoring but have no named staff or process to do it.

Output: a draft control map as a table with one row per tool and these columns: tool, vendor, configuration owner, monitoring owner, override owner, what the contract says, gap, recommended check, check owner. After the table, give a short list of contract questions for compliance and legal, and a list of open items.

My inputs: tools in production [list of clinical AI tools], vendors and relevant clauses [vendor names and contract terms or renewal dates], monitoring staff [names or roles], governance body [committee name].

Guardrails: use only the facts above and the inputs I fill in. Cite Becker's Hospital Review and the AMA by name. Flag anything uncertain or that must be verified, especially contract interpretation. Use no patient data. This is a draft for our team to check, not legal or medical advice.